{"id":1031665,"title":"DSEN Abstract: What is the comparative effectiveness and safety of sitagliptin and NPH insulin for the management of type 2 diabetes not controlled by metformin plus sulfonylurea? - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-13","captureTimestamp":"2026-02-13T20:10:31.776000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51402.html?wbdisable=true","snippet":"DSEN Abstract What is the comparative effectiveness and safety of sitagliptin and NPH insulin for the management of type 2 diabetes not controlled by metformin plus sulfonylurea? This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the…","rawSnapshotUrl":"/api/snapshots/raw/1031665","browseUrl":"https://replay.healtharchive.ca/job-8/20260213201031/https://cihr-irsc.gc.ca/e/51402.html?wbdisable=true#ha_snapshot=1031665","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}